US Stock MarketDetailed Quotes

NRSN NeuroSense Therapeutics

Watchlist
  • 1.150
  • -0.050-4.17%
Close Jan 2 16:00 ET
  • 1.150
  • 0.0000.00%
Post 17:12 ET
26.71MMarket Cap-1.51P/E (TTM)

NeuroSense Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NeuroSense Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

NeuroSense Therapeutics Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 18, 2024 11:09 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 2, 2024 16:22 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 31, 2024 17:01 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 30, 2024 16:58 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 2, 2025

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data